Healthcare stocks haven’t quite outperformed the broader markets this year, per usual, but they have performed admirably given all of the political headwinds facing the sector as a whole. The sector’s resilience during this politically turbulent period stems from several…
The stock market was once again fairly quiet on Wednesday, as the beginning of earnings season brought some mixed views about the state of the overall U.S. economy. Investors remain uncertain how policymakers will respond to the conflicting readings on…
In 2019, the vast majority of licensed cannabis producers have been losing money at a time when investors were expecting the profits to start rolling in. Among those with at least $20 million in annual sales, all but a handful…
There’s no denying that there’s a lot of buzz surrounding the cannabis space — and for good reason. First, Wall Street has tossed around some very prolific long-term sales growth figures for the global marijuana industry. While most estimates have…
Aurora Cannabis (NYSE:ACB) bulls are looking tired. ACB stock has now hit $10 on three occasions: January 2018, last fall, and most recently this March. Each time ACB stock has fallen sharply from that resistance level. If Aurora stock can’t get…
The big day, for 2019 at least, is about five months away for Canadian marijuana stocks. After officially legalizing recreational marijuana on Oct. 17, 2018, Canada’s regulatory agency Health Canada expects derivative products to first make their way onto dispensary-store…
